Recently, it was reported that genetic variants in the GMNC‐OSTN region on chromosome 3 (described in detail in this study) were associated both with smaller ventricles and with increased CSF levels of the AD biomarker P‐tau (Jansen et al, 2022). Here, MAPT is linked to Alzheimer disease.